Tenofovir Disoproxil Fumarate

CAS No. 202138-50-9

Tenofovir Disoproxil Fumarate ( Bis(POC)-PMPA )

Catalog No. M13146 CAS No. 202138-50-9

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 41 In Stock
25MG 61 In Stock
50MG 83 In Stock
100MG 113 In Stock
200MG 154 In Stock
500MG 227 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tenofovir Disoproxil Fumarate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.
  • Description
    Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.
  • Synonyms
    Bis(POC)-PMPA
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV reverse transcriptase
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    202138-50-9
  • Formula Weight
    635.51
  • Molecular Formula
    C19H30N5O10P·C4H4O4
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO:128 mg/mL (201.41 mM)
  • SMILES
    C(\C=C\C(=O)O)(=O)O.C(OCOP(=O)(CO[C@@H](CN1C2=NC=NC(=C2N=C1)N)C)OCOC(OC(C)C)=O)(OC(C)C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Murphy RA,etal.Establishment of HK-2 Cells as a Relevant Model to Study Tenofovir-Induced Cytotoxicity.Int J Mol Sci. 2017 Mar 1;18(3).
molnova catalog
related products
  • Raltegravir potassiu...

    A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.

  • Nef-IN-B9

    Nef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM.

  • HIV-1 Rev 34-50

    HIV-1 Rev (34-50) is a 17-aa peptide derived from the Rev-responsive element (RRE)-binding domains of Rev in HIV-1, with anti-HIV-1 activity. HIV-1 Rev peptide is a one of the cell-penetrating peptides (CPPs) derived from HIV-1 Rev protein residue 34-50. It is a RNA binding peptideand has been used to deliver macromolecules into cells.